Neonatal asphyxia – Diagnostics – Overview of Information and Clinical Research

Neonatal asphyxia is a serious medical condition that occurs when a newborn baby does not receive enough oxygen before, during, or right after birth. This lack of oxygen can affect the brain and other vital organs, sometimes leading to lasting health problems. Early recognition and proper diagnostic testing are crucial for identifying babies who need immediate medical attention and specialized treatment.

Introduction: Who Should Undergo Diagnostics

Not every baby needs extensive diagnostic testing for neonatal asphyxia, but certain situations raise red flags that prompt medical teams to take a closer look. Doctors and nurses carefully observe newborns immediately after birth, watching for any signs that the baby may have experienced oxygen deprivation during the delivery process.^[1]

Diagnostic evaluation becomes especially important when a baby shows visible signs of distress at birth. These signs might include difficulty breathing or not breathing at all, unusual skin color such as bluish or grayish tones, a very slow heart rate, weak muscle tone, or poor reflexes. Any baby who needs help to breathe or maintain a heartbeat in the delivery room should undergo diagnostic assessment for possible asphyxia.^[2]

Certain birth circumstances also increase the likelihood that a baby will need diagnostic testing. If there were complications during labor such as the placenta separating from the womb too early, problems with the umbilical cord during delivery, a very long or difficult delivery, or significant blood loss during labor, doctors will carefully evaluate the newborn for signs of oxygen deprivation. Similarly, if the mother experienced severe health problems during pregnancy or delivery that could have affected oxygen flow to the baby, diagnostic testing becomes necessary.^[12]

Parents should understand that seeking diagnostic evaluation is not something they need to request themselves. The medical team attending the birth is trained to recognize when a baby might have experienced asphyxia and will automatically begin the appropriate assessments. However, if parents notice that their baby seems particularly weak, is having trouble feeding, appears unusually floppy or stiff, or has seizures in the hours or days following birth, they should immediately alert their healthcare providers.^[7]

⚠️ Important

Time is critical when diagnosing neonatal asphyxia. The medical team must act quickly because brain damage can begin within minutes when a baby does not receive enough oxygen. Most diagnostic tests happen immediately in the delivery room or within the first few hours after birth to identify babies who need urgent treatment such as cooling therapy, which must begin within six hours of birth to be most effective.

Classic Diagnostic Methods

The first and most immediate diagnostic tool used to assess whether a newborn has experienced asphyxia is the Apgar score. This scoring system was developed to provide a quick, standardized way to evaluate a baby’s condition immediately after birth. Doctors and nurses check the baby at one minute after birth and again at five minutes after birth, assigning points for five different characteristics: skin color, heart rate, muscle tone, reflexes, and breathing effort.^[2]

Each characteristic receives a score from zero to two points, making the total possible score ten points. A score of seven to ten at five minutes is considered normal, indicating the baby is doing well. A score between four and six suggests the baby needs some medical attention and monitoring. A very low Apgar score of zero to three, especially if it continues beyond ten minutes, may indicate that the baby has experienced significant oxygen deprivation and could be developing hypoxic-ischemic encephalopathy, which is the medical term for brain damage caused by lack of oxygen and blood flow.^[7]

While the Apgar score provides valuable initial information, doctors need additional tests to confirm whether a baby has truly experienced asphyxia and to determine its severity. One crucial test involves analyzing the baby’s blood to check for signs of metabolic acidosis. When cells do not receive enough oxygen, they must switch to a less efficient process called anaerobic metabolism, which produces lactic acid as a byproduct. This causes the blood to become too acidic.^[1]

To check for acidosis, the medical team takes a sample of blood from the umbilical cord at birth or from the baby shortly after birth. They measure the blood’s pH level and look at something called the base deficit, which indicates how much acid has accumulated. A pH level less than 7.20 in the umbilical cord blood, combined with other signs, suggests the baby experienced significant oxygen deprivation. These blood tests provide objective measurements that help doctors understand how severely the baby’s body was affected by the lack of oxygen.^[5]

Beyond the immediate scoring and blood tests, doctors perform a thorough physical examination of the newborn to look for signs of abnormal brain function. This examination helps identify encephalopathy, which means dysfunction or damage to the brain. The doctor checks whether the baby has normal muscle tone or appears either too floppy (called hypotonia) or too stiff. They test the baby’s reflexes, particularly the sucking reflex, which should be strong in healthy newborns. They observe the baby’s eye movements and how the pupils respond to light. They also watch carefully for any abnormal movements or seizures.^[1]

These clinical signs of encephalopathy are classified into stages to help determine the severity of brain involvement. Stage one, or mild encephalopathy, might show up as increased alertness, slight muscle stiffness, and strong reflexes. Stage two, or moderate encephalopathy, typically involves decreased muscle tone, weak reflexes, and possibly seizures. Stage three, or severe encephalopathy, presents with very poor muscle tone, absent reflexes, and often seizures that are difficult to control. This staging helps guide treatment decisions and provides information about possible outcomes.^[2]

When there are concerns about brain injury, doctors often order imaging studies to visualize the brain directly. Magnetic resonance imaging, or MRI, is particularly helpful for identifying patterns of brain damage caused by oxygen deprivation. MRI scans use magnetic fields and radio waves to create detailed pictures of the brain’s structure. The test is painless but requires the baby to lie very still, sometimes requiring sedation. MRI can show characteristic patterns of injury that occur specifically with hypoxic-ischemic brain damage, helping doctors confirm the diagnosis and predict which areas of the brain might be affected.^[1]

Another important diagnostic tool is the electroencephalogram, or EEG, which measures the electrical activity in the brain. Electrodes are placed on the baby’s scalp to detect the tiny electrical signals that brain cells use to communicate. In babies with asphyxia-related brain injury, the EEG may show abnormal patterns or decreased activity. EEG monitoring is especially important for detecting seizures, which may not always be visible from the outside but can cause additional harm to an already injured brain. Continuous EEG monitoring allows the medical team to spot seizures quickly and treat them promptly.^[17]

Doctors also evaluate how other organs in the baby’s body have been affected, because severe asphyxia does not only harm the brain. Blood tests can check kidney function by measuring waste products that the kidneys should filter out. Liver function tests assess whether liver cells were damaged. Heart monitoring through electrocardiogram can reveal whether the heart muscle was injured by lack of oxygen. Chest X-rays might be needed if there are concerns about lung problems. This comprehensive approach helps medical teams understand the full extent of injury and provide appropriate support for all affected organs.^[7]

⚠️ Important

Diagnostic tests for neonatal asphyxia serve multiple purposes beyond just confirming the diagnosis. They help doctors decide which babies need specialized treatments like therapeutic cooling, monitor how babies respond to treatment, identify complications early, and provide families with information about what to expect for their child’s future development and health needs.

Diagnostics for Clinical Trial Qualification

When babies are being considered for enrollment in clinical trials testing new treatments for neonatal asphyxia or its complications, they must undergo specific diagnostic evaluations to determine whether they meet the study’s requirements. Clinical trials have strict criteria to ensure that only appropriate candidates receive experimental treatments and that researchers can accurately measure whether the treatments work.^[1]

The Apgar scoring system remains a fundamental criterion for clinical trial enrollment. Many studies specifically require that babies have documented low Apgar scores at specific time points after birth. For example, a trial might require an Apgar score of five or less at ten minutes after birth. This standardized measurement helps researchers ensure that all babies in the study experienced a similar level of distress at birth, making it easier to compare results across participants.^[2]

Blood gas analysis showing metabolic acidosis is typically another mandatory requirement for clinical trial participation. Researchers need objective proof that the baby experienced significant oxygen deprivation, not just visible distress. Most trials set specific thresholds, such as requiring umbilical cord blood pH less than 7.0, or less than 7.15 combined with a base deficit of at least 10. These numbers provide concrete evidence that the baby’s cells were deprived of oxygen long enough to switch to anaerobic metabolism and accumulate dangerous levels of acid.^[5]

Clinical evidence of encephalopathy is almost always required for babies to qualify for clinical trials studying treatments for asphyxia-related brain injury. The baby must show clear neurological signs such as abnormal muscle tone, impaired reflexes, or seizures that cannot be explained by other causes like genetic disorders, metabolic problems, or medication effects. Many trials use specific standardized scoring systems to classify the severity of encephalopathy, ensuring that researchers can accurately compare outcomes between different babies and different treatment groups.^[1]

The timing of birth is often another critical factor for clinical trial qualification. Many experimental treatments, particularly cooling therapy trials, only include babies born after a certain gestational age, typically 35 or 36 weeks of pregnancy. This is because premature babies’ bodies respond differently to treatments and face different risks, making it difficult to compare them directly with babies born closer to full term. Additionally, some treatments must begin within a specific time window after birth, commonly within six hours, which becomes part of the eligibility criteria.^[2]

Neuroimaging studies play an important role in qualifying babies for certain clinical trials, particularly those testing therapies aimed at repairing or protecting brain tissue. Some trials require that MRI scans show specific patterns of brain injury consistent with hypoxic-ischemic damage before a baby can enroll. Other trials might use early imaging to exclude babies with certain types of severe brain injury that are unlikely to benefit from the experimental treatment. The timing of these scans varies by study protocol, with some requiring imaging within the first days of life and others waiting until later in the first week.^[1]

Continuous EEG monitoring may be used both as a qualification criterion and as a monitoring tool during clinical trials. Some studies require documented seizure activity or specific abnormal brain wave patterns for enrollment. Once enrolled, ongoing EEG monitoring helps researchers track changes in brain activity that might indicate whether the experimental treatment is working. This neurophysiological data provides insights into brain function that cannot be obtained through observation alone.^[17]

Clinical trials often require extensive documentation of multi-organ involvement to understand the full impact of asphyxia on the baby’s body. This means babies entering trials undergo comprehensive testing of kidney function, liver function, heart function, and blood clotting ability. Researchers use these baseline measurements to track whether experimental treatments help protect these organs or whether they only affect the brain. Some trials specifically target babies with certain patterns of organ involvement, making these diagnostic tests part of the screening process.^[7]

Exclusion criteria are just as important as inclusion criteria in clinical trials. Diagnostic tests help identify babies who should not participate in certain studies. For example, babies with major genetic abnormalities, severe birth defects, or evidence of infection might be excluded because these conditions could interfere with evaluating the experimental treatment’s effectiveness. Comprehensive screening ensures that study results reflect the treatment’s true impact on asphyxia rather than the effects of other complicating conditions.^[1]

Prognosis and Survival Rate

Prognosis

The outlook for babies who experience neonatal asphyxia varies significantly depending on how severe and prolonged the oxygen deprivation was, and how quickly they received appropriate treatment. Babies with mild or moderate hypoxic-ischemic encephalopathy may recover fully without any lasting problems. Their brain cells may have been temporarily affected but can heal completely with proper medical support. However, babies who experienced more severe or prolonged oxygen deprivation may develop permanent injuries affecting their brain, heart, lungs, kidneys, or other organs.^[2]

The severity of encephalopathy observed in the first days after birth provides important clues about the baby’s likely outcome. Infants with mild encephalopathy generally have excellent prospects for normal development. Those with moderate encephalopathy face approximately a 10 percent risk of death and about a 30 percent risk of developing disabilities among survivors. Babies with severe encephalopathy face the most serious challenges, with roughly 60 percent not surviving and nearly all survivors experiencing some form of disability.^[2]

Several factors influence the prognosis. The amount of harm depends critically on how long the baby went without adequate oxygen and how quickly medical teams were able to provide the right treatment. Therapeutic hypothermia, or whole-body cooling, has emerged as the only proven treatment that can improve outcomes for babies born after 35 weeks of pregnancy who have moderate or severe hypoxic-ischemic encephalopathy. This treatment must begin within six hours of birth to provide maximum benefit.^[2]

Long-term outcomes can range widely. Some babies may have no ongoing health concerns, while others might experience mild learning difficulties or developmental delays. More significantly affected children may develop cerebral palsy, which affects movement and muscle control, or intellectual disabilities that impact learning and daily functioning. The specific areas of the brain that were injured determine which functions might be impaired. For instance, injury to motor control areas can cause movement problems, while damage to other regions might affect speech, vision, or cognitive abilities.^[7]

Brain imaging studies, particularly MRI performed in the first week or two of life, help doctors predict outcomes more accurately. Certain patterns of injury seen on MRI scans correlate with specific types of developmental problems. However, some children surprise doctors by doing better than expected, while others face more challenges than initial tests suggested. This unpredictability makes it important for families to maintain regular follow-up appointments so doctors can monitor development and provide early intervention services when needed.^[1]

Survival Rate

Neonatal asphyxia remains a serious condition that contributes significantly to infant deaths worldwide. The World Health Organization estimates that birth asphyxia accounts for approximately 900,000 neonatal deaths globally each year, representing about 23 percent of all newborn deaths and 10 percent of all deaths in children under five years of age.^[5]^[6]

Survival rates vary considerably based on the severity of asphyxia and the resources available for treatment. In the most severe cases where babies experience profound oxygen deprivation, asphyxia can lead to cardiac arrest and death within minutes if resuscitation is not successful. Even with successful initial resuscitation, babies with severe hypoxic-ischemic encephalopathy face mortality rates approaching 60 percent.^[2]

The availability and timing of specialized treatments significantly impact survival. In healthcare facilities with access to therapeutic hypothermia and neonatal intensive care units equipped to handle complex cases, survival rates are considerably better than in settings without these resources. Early recognition of asphyxia in the delivery room, prompt resuscitation following established guidelines, and rapid transfer to appropriate facilities when needed all contribute to improved survival outcomes.^[6]

Geographic and economic factors play important roles in survival statistics. Perinatal asphyxia occurs in approximately 2 to 10 per 1,000 newborns born at term in developed countries, with higher rates in premature births. However, outcomes differ dramatically between high-resource and low-resource settings. In areas with limited access to skilled birth attendants, resuscitation equipment, and intensive care facilities, more babies die from birth asphyxia that might have been survivable with adequate medical resources.^[5]

#1 Clinical Trials Search in Europe